As PBM pressure mounts and formulary bidding wars squeeze manufacturers, a direct access marketplace model offers drug makers a path to compete on efficacy, price and real-world outcomes.
Bret Parker
Advertisement
Bret Parker is SVP, pharma solutions, at Prescryptive Health.
Articles by Bret Parker
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How CMS’ Final Negotiation Rule Treats New Drug Formulations
2
Report: 2026 Patient Support Awards Name Leaders in Large, Small Pharma
3
Big Three Distributors Lean on Specialty for Profit Growth
4
ELPRO CEO on How Biologics Raised the Stakes in Cold Chain Handling
5